AbbVie (ABBV) EVP Demetris Crum surrenders 1,594 shares for tax withholding

Rhea-AI Filing Summary

AbbVie Inc. executive Demetris D. Crum, EVP and Chief HR Officer, reported a tax-related share disposition. On February 27, 2026, Crum disposed of 1,594 shares of AbbVie common stock at $232.08 per share to satisfy tax withholding obligations, a non‑open‑market transaction coded as a tax‑withholding disposition. After this event, Crum directly owned 7,914 AbbVie shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Crum Demetris D

(Last) (First) (Middle)

1 N. WAUKEGAN ROAD

(Street)

NORTH CHICAGO IL 60064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CHIEF HR OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value	02/27/2026		F		1,594	D	$232.08	7,914	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ T.O. Odutayo, Attorney-in-Fact for Demetris D. Crum	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AbbVie (ABBV) executive Demetris D. Crum report?

Demetris D. Crum reported a tax-withholding disposition of AbbVie shares. On February 27, 2026, he disposed of 1,594 common shares at $232.08 per share to cover tax obligations associated with equity compensation.

Was Demetris D. Crum’s AbbVie (ABBV) Form 4 transaction an open-market sale?

No, the transaction was a tax-withholding disposition, not an open-market sale. It is coded “F”, meaning shares were surrendered to satisfy tax liabilities tied to equity awards, rather than sold on the open market.

How many AbbVie (ABBV) shares does Demetris D. Crum hold after this Form 4?

After the tax-withholding disposition, Demetris D. Crum directly holds 7,914 AbbVie common shares. This figure reflects his remaining direct ownership following the surrender of 1,594 shares for tax purposes on February 27, 2026.

What does transaction code “F” mean in the AbbVie (ABBV) Form 4 for Demetris D. Crum?

Transaction code “F” indicates payment of an exercise price or tax liability by delivering securities. In this AbbVie filing, Crum’s 1,594-share disposition was specifically characterized as a tax-withholding event rather than a typical stock sale.

What role does Demetris D. Crum hold at AbbVie (ABBV) in this Form 4 filing?

In this Form 4, Demetris D. Crum is identified as AbbVie’s Executive Vice President and Chief Human Resources Officer. The reported tax-withholding disposition relates to his equity compensation as a senior officer of the company.